Autopsy report · NCT02567578

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

“Technology transfer”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 5 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Yuhan Corporation

Sponsor type

Industry

Conditions

Functional Dyspepsia

Interventions

YH12852 0.1 mg; YH12852 0.25 mg; YH12852 0.5 mg; Placebo

Participants

12

Sites

1

Countries

South Korea

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.